Navigation Links
Erectile Dysfunction May Signal Hidden Heart Disease
Date:1/30/2013

rlying cardiovascular disease," Banks said.

Doctors already believe that erectile dysfunction is an early warning sign of heart problems, but it's not clear why. It's possible, Banks said, that the arteries of the penis are smaller than those of other parts of the body and may be more likely to reveal problems when their lining deteriorates.

The new study aims to gain more insight into how the severity of erectile dysfunction translates into a higher risk of cardiovascular disease. The researchers tracked more than 95,000 men aged 45 and up, and compared data collected between 2006 and 2009 to data collected in 2010.

The researchers adjusted their statistics so they wouldn't be thrown off by factors like high or low numbers of men who smoked or drank alcohol, or were wealthy or poor. They found that the men with severe erectile dysfunction, compared to those with no problem, were eight times more likely to have heart failure, 60 percent more likely to have heart disease and almost twice as likely to die of any cause.

What does this mean in the big picture?

"Heart problems are very common, so even a relatively moderate increase in risk translates into quite a number of affected individuals," Banks said. "Among men with no past history of cardiovascular disease, an estimated six per 1,000 men per year who did not have erectile dysfunction went on to be admitted to the hospital for coronary heart disease. This compares with eight per 1,000 men per year with moderate erectile dysfunction and nine per 1,000 men per year among those with severe erectile dysfunction."

Also, she said, "among men with a past history of cardiovascular disease, an estimated 20 per 1,000 men per year of those without erectile dysfunction went on to be admitted to the hospital for coronary artery disease. This compares with 28 per 1,000 men per year with moderate erectile dysfunction and 34 per 1,000 men per year with severe erectile dysfunction."

Cou
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Erectile dysfunction drug also helps men ejaculate and orgasm
2. Advanced Male Medical Center Provides New and Effective Therapies to Treat Erectile Dysfunction
3. Grief is not a disease, but cancer is -- what about erectile dysfunction?
4. Miriam researchers urge physicians to ask younger men about erectile dysfunction symptoms
5. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
6. Erectile dysfunction drug may benefit cardiac function in young patients with heart defects
7. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
8. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at the Center for Regenerative Medicine in Miami
9. Experts issue recommendations for treating thyroid dysfunction during and after pregnancy
10. As a mans belt size increases, so does his risk of sexual and urinary dysfunction
11. Classifying neural circuit dysfunctions using neuroeconomics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Erectile Dysfunction May Signal Hidden Heart Disease
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... Albany, NY (PRWEB) November 26, 2014 ... industry research requirements or email the details on sales(at)researchmoz(dot)us ... "Worldwide diabetes and drug discovery market 2014" with deep ... Diabetes is the result of high blood sugar. The ... is directly linked to the growing number of diabetics ...
(Date:11/26/2014)... 26, 2014 News Facts , ... capabilities at RSNA 2014 in Chicago. The company ... share diagnostic images, photos, videos and documents found ... #8107 will learn more about these innovative medical ... and partner initiatives – that enable more informed ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
(Date:11/26/2014)... -- Parents need to take an active role in ... Parents must make sure sports-playing teens have the ... chair of the American Migraine Foundation and a professor ... in Scottsdale, Ariz. in an American Migraine Foundation, said ... involved with teens sports needs to have appropriate training. ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... , MONDAY, May 21 (HealthDay News) -- The new blood ... blood clots in high-risk heart patients, a U.S. Food and ... briefing documents that were filed Monday in advance of an ... to vote on whether to recommend approval of Xarelto for ...
... HealthDay Reporter , MONDAY, May 21 (HealthDay News) -- ... helps overweight women lower the levels of certain hormones in ... breast cancer. The findings don,t ... Still, women who take medications to prevent the disease "need ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... be reducing their risk of psoriasis, Harvard University researchers report. ... scaly patches on the skin. Vigorous activity for ... risk by 25 percent to 30 percent, the researchers said. ...
... scientist from the Viral Immunology Center at Georgia State ... of the eye is associated with neovascular age-related macular ... elderly. The scientists found that human cytomegalovirus, a ... growth factor, or VEGF, a signal protein that regulates ...
... A team of scientists has developed a promising new ... shrink and die. The researchers hope that their discovery ... drug that effectively targets unhealthy, cancerous tissue without damaging ... be published in the Journal of Biological Chemistry ...
... went to John Edward Solder, a senior at Staples ... Interrogation of Prefrontal Cortex Dopamine D1 Receptor-Containing Neurons as ... Treat Prefrontal Disorders. The 18-year-old was able to specifically ... to activate dopamine neurons in the prefrontal cortex, a ...
Cached Medicine News:Health News:New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA 2Health News:Dieting May Lower Hormone Levels Tied to Breast Cancer 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 3Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:Strategy discovered to activate genes that suppress tumors and inhibit cancer 2Health News:Strategy discovered to activate genes that suppress tumors and inhibit cancer 3Health News:Optogenetics project takes top NIDA Addiction Science Award 2Health News:Optogenetics project takes top NIDA Addiction Science Award 3Health News:Optogenetics project takes top NIDA Addiction Science Award 4
(Date:11/26/2014)... Pa. , Nov. 25, 2014  Unilife Corporation ... of injectable drug delivery systems, today announced that its ... to present at the Piper Jaffray 26th Annual Healthcare ... a.m. EST on Tuesday, December 2, 2014. ... Internet as a "live" listen only Webcast. To listen, ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 /PRNewswire/ ... AZN ) today announced that AMAGINE-2 TM , ... brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, ... (ustekinumab) and placebo at week 12. Brodalumab 210 mg ... were each shown to be superior to Stelara on the ...
(Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... Delcath Systems, Inc. (Nasdaq: DCTH ) ... Senior Vice President of Medical Device Research and Development ... to the position of Vice President of Pharmaceutical Research ... based in the Company,s Queensbury, New York facility and ...
... Thomson Reuters, a global provider of information ... version of its award-winning Clinical Xpert Navigator ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090507/NY12658LOGO) (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO) ... to access complete patient clinical data — ...
Cached Medicine Technology:Delcath Strengthens Research and Development Team with Key Appointments 2Delcath Strengthens Research and Development Team with Key Appointments 3Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator 2Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: